Skip to content

To Evaluate The Shulaghna Effect Of Hingvadi Churna In Udavartini Yonivyapad

Randomised Controlled Clinical Trial To Evaluate The Shulaghna Effect Of Hingvadi Churna In The Management Of Udavartini Yonivyapad With Special Reference To Primary Dysmenorrhia - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082011
Enrollment
60
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Nikita Raju Bisen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling diagnostic criteria patients complaining of pain during menses with other symptoms of Udavartini Yonivyapada for at least three consecutive cycles Patients with age group of 16 to 30 years old. Married and unmarried patients Patient with scanty or average flow

Exclusion criteria

Exclusion criteria: Patient having irregular menstruation. Patient having congestive, poly or epi menorrhea Patient having anatomical and congenital anomalies in genital tract. Patient with Fibroid, cyst, endometriosis. Patient suffering from any systemic disease like HTN, DM, bleeding disorder, cardiac disease, APH, PIH. Presence of HIV,HbsAg,VDRL,HPV Positive in the patient. Patient using any IUCDs. Patient having an endocrinological disorder like Hypothyroidism Hyperthyroidism

Design outcomes

Primary

MeasureTime frame
Significantly reduction in pain during mensesTimepoint: 2 Consecutive menstrual cycle

Secondary

MeasureTime frame
Significantly reduction in pain during menses by using Higvadi churna than Yavani churnaTimepoint: 2 Consecutive menstrual cycle

Countries

India

Contacts

Public ContactDrRutuja Gaikwad

R A Podar Ayurvedic Medical College Worli Mumbai

drrutujasg@gmail.com9699825626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026